218 related articles for article (PubMed ID: 7944071)
1. Cholesterol and coronary heart disease: predicting risks by levels and ratios.
Kinosian B; Glick H; Garland G
Ann Intern Med; 1994 Nov; 121(9):641-7. PubMed ID: 7944071
[TBL] [Abstract][Full Text] [Related]
2. Cholesterol and coronary heart disease: predicting risks in men by changes in levels and ratios.
Kinosian B; Glick H; Preiss L; Puder KL
J Investig Med; 1995 Oct; 43(5):443-50. PubMed ID: 8528755
[TBL] [Abstract][Full Text] [Related]
3. Clinical utility of different lipid measures for prediction of coronary heart disease in men and women.
Ingelsson E; Schaefer EJ; Contois JH; McNamara JR; Sullivan L; Keyes MJ; Pencina MJ; Schoonmaker C; Wilson PW; D'Agostino RB; Vasan RS
JAMA; 2007 Aug; 298(7):776-85. PubMed ID: 17699011
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of cholesterol levels and ratios in predicting future coronary heart disease in a Chinese population.
Wang TD; Chen WJ; Chien KL; Seh-Yi Su SS; Hsu HC; Chen MF; Liau CS; Lee YT
Am J Cardiol; 2001 Oct; 88(7):737-43. PubMed ID: 11589839
[TBL] [Abstract][Full Text] [Related]
5. Cholesterol measures to identify and treat individuals at risk for coronary heart disease.
Natarajan S; Glick H; Criqui M; Horowitz D; Lipsitz SR; Kinosian B
Am J Prev Med; 2003 Jul; 25(1):50-7. PubMed ID: 12818310
[TBL] [Abstract][Full Text] [Related]
6. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
Downs JR; Clearfield M; Weis S; Whitney E; Shapiro DR; Beere PA; Langendorfer A; Stein EA; Kruyer W; Gotto AM
JAMA; 1998 May; 279(20):1615-22. PubMed ID: 9613910
[TBL] [Abstract][Full Text] [Related]
7. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM
Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751
[TBL] [Abstract][Full Text] [Related]
8. Search for an optimal atherogenic lipid risk profile: from the Framingham Study.
Nam BH; Kannel WB; D'Agostino RB
Am J Cardiol; 2006 Feb; 97(3):372-5. PubMed ID: 16442398
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein B improves risk assessment of future coronary heart disease in the Framingham Heart Study beyond LDL-C and non-HDL-C.
Pencina MJ; D'Agostino RB; Zdrojewski T; Williams K; Thanassoulis G; Furberg CD; Peterson ED; Vasan RS; Sniderman AD
Eur J Prev Cardiol; 2015 Oct; 22(10):1321-7. PubMed ID: 25633587
[TBL] [Abstract][Full Text] [Related]
10. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
Bersot TP; Pépin GM; Mahley RW
Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
[TBL] [Abstract][Full Text] [Related]
11. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment.
Manninen V; Tenkanen L; Koskinen P; Huttunen JK; Mänttäri M; Heinonen OP; Frick MH
Circulation; 1992 Jan; 85(1):37-45. PubMed ID: 1728471
[TBL] [Abstract][Full Text] [Related]
12. Low high-density lipoprotein cholesterol and other coronary heart disease risk factors in patients with total cholesterol levels greater than 5.17 mmol/L (200 mg/dL) in family practice. A report from CEN.
J Am Board Fam Pract; 1991; 4(5):285-97. PubMed ID: 1746296
[TBL] [Abstract][Full Text] [Related]
13. Improving the prediction of cardiovascular risk: interaction between LDL and HDL cholesterol.
Grover SA; Dorais M; Coupal L
Epidemiology; 2003 May; 14(3):315-20. PubMed ID: 12859032
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol.
Alsheikh-Ali AA; Lin JL; Abourjaily P; Ahearn D; Kuvin JT; Karas RH
Am J Cardiol; 2007 Nov; 100(10):1499-501. PubMed ID: 17996508
[TBL] [Abstract][Full Text] [Related]
15. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.
Clearfield MB; Weis SE; Willis JM; Vasenius KA; McConathy WJ
J Am Osteopath Assoc; 2002 Jul; 102(7):377-84. PubMed ID: 12138952
[TBL] [Abstract][Full Text] [Related]
16. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group.
Rubins HB; Robins SJ; Collins D; Fye CL; Anderson JW; Elam MB; Faas FH; Linares E; Schaefer EJ; Schectman G; Wilt TJ; Wittes J
N Engl J Med; 1999 Aug; 341(6):410-8. PubMed ID: 10438259
[TBL] [Abstract][Full Text] [Related]
17. Total cholesterol, low density lipoprotein cholesterol, and high density lipoprotein cholesterol and coronary heart disease in Scotland.
Hargreaves AD; Logan RL; Thomson M; Elton RA; Oliver MF; Riemersma RA
BMJ; 1991 Sep; 303(6804):678-81. PubMed ID: 1912914
[TBL] [Abstract][Full Text] [Related]
18. Plasma triglyceride level and mortality from coronary heart disease.
Criqui MH; Heiss G; Cohn R; Cowan LD; Suchindran CM; Bangdiwala S; Kritchevsky S; Jacobs DR; O'Grady HK; Davis CE
N Engl J Med; 1993 Apr; 328(17):1220-5. PubMed ID: 8464432
[TBL] [Abstract][Full Text] [Related]
19. Is Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor? New Insights From the Framingham Offspring Study.
Bartlett J; Predazzi IM; Williams SM; Bush WS; Kim Y; Havas S; Toth PP; Fazio S; Miller M
Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):206-212. PubMed ID: 27166203
[TBL] [Abstract][Full Text] [Related]
20. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk.
Walldius G; Jungner I; Aastveit AH; Holme I; Furberg CD; Sniderman AD
Clin Chem Lab Med; 2004; 42(12):1355-63. PubMed ID: 15576296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
